Maravai LifeSciences Holdings Inc (NAS:MRVI)
$ 11.32 0.22 (1.98%) Market Cap: 1.50 Bil Enterprise Value: 1.48 Bil PE Ratio: 0 PB Ratio: 3.59 GF Score: 75/100

Maravai LifeSciences Holdings Inc at Jefferies London Healthcare Conference Transcript

Nov 16, 2023 / 02:00PM GMT
Release Date Price: $5.11 (-1.54%)
Brandon Couillard
Jefferies LLC, Research Division - Equity Analyst

Good afternoon. Thanks for being here at the last session of our London conference. We're very excited to have Maravai LifeSciences with us today, here to tell us more about the story before we jump into some Q&A, CEO, Trey Martin; as well as CFO, Kevin Herde. Turn it over to Trey.

William E. Martin
Maravai LifeSciences Holdings, Inc. - CEO

All right. Thank you. Thanks for being here in person. I know it sounds like we're at the tail end of this conference and also thanks to those who are joining us online. As with every other presentation you'll probably see today, we'll be making forward-looking statements using some non-GAAP terms such as adjusted EBITDA. And we have, of course, all of our risk factors listed in our SEC filings on the website.

All right. I thought I would start for this group with a little bit of the history of Maravai, where it came from and where it's going. So Maravai is almost a 10-year-old company. As of next March, that will be the 10-year anniversary.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot